The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease

Bibliography

• Li B, Duysen EG, Carlson M, et al. The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency. J Pharmacol Exp Ther 2008;324:1146-54
   PubMed Web of Science ®Google Scholar
• Souza RL, Mikami LR, Maegawa RO, et al. Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample. Mol Genet Metab 2005;84:349-53
   PubMed Web of Science ®Google Scholar
• Bartels CF, Jensen FS, Lockridge O, et al. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 1992;50:1086-103
   PubMed Web of Science ®Google Scholar
• Om A, Ellahham S, Ornato JP, et al. Medical complications of cocaine: possible relationship to low plasma cholinesterase enzyme. Am Heart J 1993;125:1114-7
   PubMed Web of Science ®Google Scholar
• Duysen EG, Li B, Carlson M, et al. Increased hepatotoxicity and cardiac fibrosis in cocaine-treated butyrylcholinesterase knockout mice. Basic Clin Pharmacol Toxicol 2008;103:514-21
   PubMed Web of Science ®Google Scholar
• Saxena A, Sun W, Dabisch PA, et al. Efficacy of human serum butyrylcholinesterase against sarin vapor. Chem Biol Interact 2008;175:267-72
   PubMed Web of Science ®Google Scholar
• Masson P, Nachon F, Broomfield CA, et al. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters. Chem Biol Interact 2008;175:273-80
   PubMed Web of Science ®Google Scholar
• Lenz DE, Maxwell DM, Koplovitz I, et al. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem Biol Interact 2005;157-158:205-10
   PubMed Web of Science ®Google Scholar
• Chilukuri N, Duysen EG, Parikh K, et al. Adenovirus-mediated gene transfer of human butyrylcholinesterase results in persistent high-level transgene expression in vivo. Chem Biol Interact 2008;175:327-31
   PubMed Web of Science ®Google Scholar
• Li B, Duysen EG, Saunders TL, et al. Production of the butyrylcholinesterase knockout mouse. J Mol Neurosci 2006;30:193-5
   PubMed Web of Science ®Google Scholar
• Available from: http://jaxmice.jax.org/strain/008087.html
   Google Scholar
• Manoharan I, Boopathy R, Darvesh S, et al. A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. Clin Chim Acta 2007;378:128-35
   PubMed Web of Science ®Google Scholar
• Manoharan I, Kuznetsova A, Fisk JD, et al. Comparison of cognitive functions between people with silent and wild-type butyrylcholinesterase. J Neural Transm 2007;114:939-45
   PubMed Web of Science ®Google Scholar
• Lockridge O. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. Pharmacol Ther 1990;47:35-60
   PubMed Web of Science ®Google Scholar
• Perez Guillermo F, Martinez Pretel CM, Tarin Royo F, et al. Prolonged suxamethonium-induced neuromuscular blockade associated with organophosphate poisoning. Br J Anaesth 1988;61:233-6
   PubMed Web of Science ®Google Scholar
• Duysen EG, Li B, Darvesh S, et al. Sensitivity of butyrylcholinesterase knockout mice to (-)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Toxicology 2007;233:60-9
   PubMed Web of Science ®Google Scholar
• Boudinot E, Taysse L, Daulon S, et al. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase. Pharmacol Biochem Behav 2005;80:53-61
   PubMed Web of Science ®Google Scholar
• Hoffman RS, Henry GC, Howland MA, et al. Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med 1992;21:247-53
   PubMed Web of Science ®Google Scholar
• Hoffman RS, Henry GC, Wax PM, et al. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice. J Pharmacol Exp Ther 1992;263:698-702
   PubMed Web of Science ®Google Scholar
• Karch SB. Cocaine cardiovascular toxicity. South Med J 2005;98:794-9
   PubMed Web of Science ®Google Scholar
• De Vriese C, Gregoire F, Lema-Kisoka R, et al. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 2004;145:4997-5005
   PubMed Web of Science ®Google Scholar
• Li B, Duysen EG, Lockridge O. The butyrylcholinesterase knockout mouse is obese on a high-fat diet. Chem Biol Interact 2008;175:88-91
   PubMed Web of Science ®Google Scholar
• Kutty KM, Huang SN, Kean KT. Pseudocholinesterase in obesity: hypercaloric diet induced changes in experimental obese mice. Experientia 1981;37:1141-2
   PubMedGoogle Scholar
• Kutty KM, Payne RH. Serum pseudocholinesterase and very-low-density lipoprotein metabolism. J Clin Lab Anal 1994;8:247-50
   PubMed Web of Science ®Google Scholar
• Greig NH, Lahiri DK, Sambamurti K. Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. Int Psychogeriatr 2002;14(Suppl 1):77-91
   PubMed Web of Science ®Google Scholar
• Holmes C, Ballard C, Lehmann D, et al. Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation. J Neurol Neurosurg Psychiatry 2005;76:640-3
   PubMed Web of Science ®Google Scholar
• O'Brien KK, Saxby BK, Ballard CG, et al. Regulation of attention and response to therapy in dementia by butyrylcholinesterase. Pharmacogenetics 2003;13:231-9
   PubMedGoogle Scholar
• Greig NH, Utsuki T, Ingram DK, et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proc Natl Acad Sci USA 2005;102:17213-8
   PubMed Web of Science ®Google Scholar
• Cerasoli DM, Griffiths EM, Doctor BP, et al. In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger. Chem Biol Interact 2005;157-158:363-5
   PubMed Web of Science ®Google Scholar
• Doctor BP, Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 2005;157-158:167-71
   PubMed Web of Science ®Google Scholar
• Saxena A, Sun W, Luo C, et al. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice. Chem Biol Interact 2005;157-158:199-203
   PubMed Web of Science ®Google Scholar
• Sun W, Doctor BP, Saxena A. Safety and pharmacokinetics of human serum butyrylcholinesterase in guinea pigs. Chem Biol Interact 2005;157-158:428-9
   PubMed Web of Science ®Google Scholar
• Castro CA, Gresham VC, Finger AV, et al. Behavioral decrements persist in rhesus monkeys trained on a serial probe recognition task despite protection against soman lethality by butyrylcholinesterase. Neurotoxicol Teratol 1994;16:145-8
   PubMed Web of Science ®Google Scholar
• Brandeis R, Raveh L, Grunwald J, et al. Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacol Biochem Behav 1993;46:889-96
   PubMed Web of Science ®Google Scholar
• Duysen EG, Lockridge O. Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase. Chem Biol Interact 2008;175:119-24
   PubMed Web of Science ®Google Scholar
• Johnson ND, Duysen EG, Lockridge O. Intrathecal delivery of fluorescent labeled butyrylcholineserase to the brains of butyrylcholinesterase knock-out mice: visualization and quantification of enzyme distribution in the brain. DOI: 10.1016/J.neuro.2009.03.001
   Google Scholar
• Li B, Sedlacek M, Manoharan I, et al. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol 2005;70:1673-84
   PubMed Web of Science ®Google Scholar